These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 18089791

  • 1. Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions.
    Takino T, Saeki H, Miyamori H, Kudo T, Sato H.
    Cancer Res; 2007 Dec 15; 67(24):11621-9. PubMed ID: 18089791
    [Abstract] [Full Text] [Related]

  • 2. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration.
    Takino T, Watanabe Y, Matsui M, Miyamori H, Kudo T, Seiki M, Sato H.
    Exp Cell Res; 2006 May 01; 312(8):1381-9. PubMed ID: 16473349
    [Abstract] [Full Text] [Related]

  • 3. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
    Nabeshima K, Inoue T, Shimao Y, Okada Y, Itoh Y, Seiki M, Koono M.
    Cancer Res; 2000 Jul 01; 60(13):3364-9. PubMed ID: 10910039
    [Abstract] [Full Text] [Related]

  • 4. Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice.
    Nyalendo C, Beaulieu E, Sartelet H, Michaud M, Fontaine N, Gingras D, Béliveau R.
    Carcinogenesis; 2008 Aug 01; 29(8):1655-64. PubMed ID: 18621744
    [Abstract] [Full Text] [Related]

  • 5. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion.
    Shamamian P, Pocock BJ, Schwartz JD, Monea S, Chuang N, Whiting D, Marcus SG, Galloway AC, Mignatti P.
    Surgery; 2000 Feb 01; 127(2):142-7. PubMed ID: 10686978
    [Abstract] [Full Text] [Related]

  • 6. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, Willems PH, van Muijen GN, Swart GW.
    Cancer Res; 2005 Oct 01; 65(19):8801-8. PubMed ID: 16204050
    [Abstract] [Full Text] [Related]

  • 7. Polarized MT1-MMP-CD44 interaction and CD44 cleavage during cell retraction reveal an essential role for MT1-MMP in CD44-mediated invasion.
    Marrero-Diaz R, Bravo-Cordero JJ, Megías D, García MA, Bartolomé RA, Teixido J, Montoya MC.
    Cell Motil Cytoskeleton; 2009 Jan 01; 66(1):48-61. PubMed ID: 19023892
    [Abstract] [Full Text] [Related]

  • 8. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
    Parmo-Cabañas M, Molina-Ortiz I, Matías-Román S, García-Bernal D, Carvajal-Vergara X, Valle I, Pandiella A, Arroyo AG, Teixidó J.
    J Pathol; 2006 Jan 01; 208(1):108-18. PubMed ID: 16278822
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MT1-MMP promotes cell growth and ERK activation through c-Src and paxillin in three-dimensional collagen matrix.
    Takino T, Tsuge H, Ozawa T, Sato H.
    Biochem Biophys Res Commun; 2010 Jun 11; 396(4):1042-7. PubMed ID: 20471961
    [Abstract] [Full Text] [Related]

  • 11. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
    Muñoz-Nájar UM, Neurath KM, Vumbaca F, Claffey KP.
    Oncogene; 2006 Apr 13; 25(16):2379-92. PubMed ID: 16369494
    [Abstract] [Full Text] [Related]

  • 12. Phenylethyl isothiocyanate and its N-acetylcysteine conjugate suppress the metastasis of SK-Hep1 human hepatoma cells.
    Hwang ES, Lee HJ.
    J Nutr Biochem; 2006 Dec 13; 17(12):837-46. PubMed ID: 16563723
    [Abstract] [Full Text] [Related]

  • 13. A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1.
    Mon NN, Hasegawa H, Thant AA, Huang P, Tanimura Y, Senga T, Hamaguchi M.
    Cancer Res; 2006 Jul 01; 66(13):6778-84. PubMed ID: 16818654
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
    Borrirukwanit K, Lafleur MA, Mercuri FA, Blick T, Price JT, Fridman R, Pereira JJ, Leardkamonkarn V, Thompson EW.
    Matrix Biol; 2007 May 01; 26(4):291-305. PubMed ID: 17175151
    [Abstract] [Full Text] [Related]

  • 16. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
    Zeng ZZ, Jia Y, Hahn NJ, Markwart SM, Rockwood KF, Livant DL.
    Cancer Res; 2006 Aug 15; 66(16):8091-9. PubMed ID: 16912186
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.
    Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M.
    EMBO J; 2002 Aug 01; 21(15):3949-59. PubMed ID: 12145196
    [Abstract] [Full Text] [Related]

  • 19. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED, Popel AS.
    J Theor Biol; 2006 Jan 07; 238(1):124-45. PubMed ID: 16005020
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells.
    Ata N, Oku T, Hattori M, Fujii H, Nakajima M, Saiki I.
    Oncol Res; 1996 Jan 07; 8(12):503-11. PubMed ID: 9160354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.